SpringerProtocols: Abstract: Designing Animal Models of Alzheimer’s Disease with Amyloid Precursor Protein (APP)Transgenes

Designing Animal Models of Alzheimer’s Disease with Amyloid Precursor Protein (APP)Transgenes

By: Jeanne F. Loring²

Abstract

Full Text

Download PDF (283K)

Amyloid precursor protein (APP) and Alzheimer’s disease are irrevocably linked, as APP is cleaved to form the Aβ peptides that are the major components of amyloid plaques. One of the most resilient hypotheses about the cause of AD centers on the Aβ peptide; all genetic causes and risk factors can be fitted into a general “amyloid cascade hypothesis,” which maintains that all pathology is initiated by an abnormal accumulation of Aβ amyloid (1).

Affiliation(s): (2) Incyte Pharmaceuticals, Inc, Palo Alto, CA

Book Title: Alzheimers Disease: Methods and Protocols

Series: Methods in Molecular Medicine | Volume: 32 | Pub. Date: Dec-29-1999 | Page Range: 249-270 | DOI: 10.1385/1-59259-195-7:249

Subject: Molecular Medicine

References

Download References

1.	Hardy, J. and Allsop, D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol. Sci. 12,383–388. <Occurrence Type="DOI"><Handle>10.1016/0165-6147(91)90609-V</Handle></Occurrence>

2.	Buxbaum, J. D., Liu, K. N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., et al. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273,27,765–27,767.

3.	Goate, A., Chartier Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349, 704–706.

4.	Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., and Lannfelt, L. (1992) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1, 345–347.

5.	Murrell, J., Farlow, M., Ghetti, B., and Benson, M. D. (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254, 97–99.

6.	Chartier Harlin, M. C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., et al. (1991) Early onset Alzheimer’s disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353,844–846.

7.	Eckman, C. B., Mehta, N. D., Crook, R., Perez-tur, J., Prihar, G., Pfeiffer, E., et al. (1997) Anew pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43) Hum. Mol. Genet. 6, 2087–2089.

8.	LaFerla, F. M., Tinkle, B. T., Bieberich, C. J., Haudenschild, C. C., and Jay, G. (1995) The Alzheimer’s A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9,21–30.

9.	Sandhu, F. A., Salim, M., and Zain, S. B. (1991) Expression of the human beta-amyloid protein of Alzheimer’s disease specifically in the brains of transgenic mice. J. Biol. Chem. 266, 21,331–21,334.

10.	Nalbantoglu, J., Tirado-Santiago, G., Lahsaini, A., Poirier, J., Goncalves, O., Verge, G., et al. (1997) Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387, 500–505.

11.	Kammesheidt, A., Boyce, F. M., Spanoyannis, A. F., Cummings, B. J., Ortegon, M., Cotman, C., et al. (1992) Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloidprecursor in the brain. Proc. Natl. Acad. Sci. USA 89, 10,857–10,861.

12.	Quon, D., Wang, Y., Catalano, R., Scardina, J. M., Murakami, K., and Cordell, B. (1991) Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 352, 239–241.

13.	Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523–527.

14.	Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., et al. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 27 4,99–102.

15.	Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., et al. (1996) Familial Alzheimer’s disease-linked presenilin 1 variants elevate A beta 1-42/ 1-40 ratio in vitro and in vivo. Neuron 17, 1005–1013. <Occurrence Type="DOI"><Handle>10.1016/S0896-6273(00)80230-5</Handle></Occurrence>

16.	Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K. H., Mistl, C., Rothacher, S., et al. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94, 13,287–13,292.

17.	Staufenbiel, M., Sommer, B., and Jucker, M. (1998) Neuronal loss in APP transgenic mice. Nature 395, 755–756.

18.	Malherbe, P., Richards, J. G., Martin, J. R., Bluethmann, H., Maggio, J., and Huber, G. (1996) Lack of beta-amyloidosis in transgenic mice expressing low levels of familial Alzheimer’s disease missense mutations. Neurobiol. Aging 17, 205–214. <Occurrence Type="DOI"><Handle>10.1016/0197-4580(95)02070-5</Handle></Occurrence>

19.	Czech, C., Delaere, P., Macq, A. F., Reibaud, M., Dreisler, S., Touchet, N., et al. (1997) Proteolytical processing of mutated human amyloid precursor protein in transgenic mice. Brain Res. Mol. Brain Res. 47, 108–116. <Occurrence Type="DOI"><Handle>10.1016/S0169-328X(97)00039-9</Handle></Occurrence>

20.	Mucke, L., Masliah, E., Johnson, W. B., Ruppe, M. D., Alford, M., Rockenstein, E. M., et al. (1994) Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice. Brain Res. 666, 151–167. <Occurrence Type="DOI"><Handle>10.1016/0006-8993(94)90767-6</Handle></Occurrence>

21.	Buxbaum, J. D., Christensen, J. L., Ruefli, A. A., Greengard, P., and Loring, J. F. (1993) Expression of APP in brains of transgenic mice containing the entire human APP gene. Biochem. Biophys. Res. Commun. 197, 639–645.

22.	Lamb, B. T., Sisodia, S. S., Lawler, A. M., Slunt, H. H., Kitt, C. A., Kearns, W. G., et al. (1993) Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice. Nat. Genet. 5, 22–30.

23.	Lamb, B. T., Bardel, K.A., Kulnane, L. S., Anderson, J. J., Holtz, G., Wagner, S. L., Sisodia, S. S., and Hoeger, E. J. (1999) Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nature Neurosci. 3, 695–697.

24.	Reaume, A.G., Howland, D.S., Trusko, S.P., Savage, M.J., Lang,D.M., Greenberg, B.D., (1996) Enhanced amyloidogenic processing of the beta-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer’s disease mutations and a “humanized” A beta sequence. J. Biol. Chem. 271, 380–388.

25.	Hogan, B., Beddington, R., Costantini, F., and Lacey, E. (1994) Manipulating the Mouse Embryo, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.

26.	Zambrowicz, B., Hasty, P., and Sands, A. Mouse Mutagenesis (1998) Lexicon Genetics Incorporated, The Woodlands, TX. www. lexgen. com

27.	Internet resources for transgenic research: TBASE (The Transgenic/Targeted Mutation Database) http://www.jax.org, Transgenic List http://www.med.ic.ac.uk/db/dbbm/tglist.htm, Database of Gene Knockouts http://www.bioscience.org/knockout/knochome.htm, BioMedNet Mouse Knockout Database http://biomednet.com/db/mkmd, MGD (The Mouse Genome Database) http://www.informatics.jax.org/, The Encyclopedia of the Mouse Genome http://www.informatics.jax.org/encyclo.htm, Resources of the Jackson Laboratory http://lena.jax.org/resources/documents/imr/, The Mouse and Rat Research Home Page http://www.cco.caltech.edu:80/~mercer/html/rodent_page.html.

28.	Sauer, B. and Henderson, N. (1988) Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 85, 5166–5170.

29.	Denenberg, V. H., Hoplight, B. J., and Mobraaten, L. E. (1998) The uterine environment enhances cognitive competence. Neuroreport 9, 1667–1671.

30.	Irizarry, M. C., Soriano, F., McNamara, M., Page, K. J., Schenk, D., Games, D., and Hyman, B. T. (1997) Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17, 7053–7059.

31.	Irizarry, M. C., McNamara, M., Fedorchak, K., Hsiao, K., and Hyman, B. T. (1997) APPSw transgenic mice develop age-related Aβ deposits and neuropil abnormalities but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56, 965–973

32.	Routtenberg, A. (1997) Measuring memory in a mouse model of Alzheimer’s disease. Science 8, 839–841.

33.	Loring, J. F., Paszty, C., Rose, A., McIntosh, T. K., Murai, H., Pierce, J. E., et al. (1996) Rational design of an animal model for Alzheimer’s disease: introduction of multiple human genomic transgenes to reproduce AD pathology in a rodent. Neurobiol. Aging 17, 173–182. <Occurrence Type="DOI"><Handle>10.1016/0197-4580(95)02076-4</Handle></Occurrence>

34.	Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., et al. (1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17, 263–264.

35.	Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C. M., Perez-tur, J., et al. (1996) Increased amyloid-beta 42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710–713.

36.	Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., et al. (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939–945. <Occurrence Type="DOI"><Handle>10.1016/S0896-6273(00)80974-5</Handle></Occurrence>

37.	Baron, U., Gossen, M.,and Bujard, H. (1997) Tetracycline-controlledtranscription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res. 25, 2723–2729.

38.	Hammer, R. E., Maika, S. D., Richardson, J.A., Tang, J. P., and Taurog, J. D. (1990) Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta2m: an animal model of HLA-B27-associated human disorders. Cell 63, 1099–1112. <Occurrence Type="DOI"><Handle>10.1016/0092-8674(90)90512-D</Handle></Occurrence>

39.	Brenin, D., Look, J., Bader, M., Hubner, N., Levan, G., and Iannaccone, P. (1997) Rat embryonic stem cells: a progress report. Transplant Proc. 29, 1761–1765. <Occurrence Type="DOI"><Handle>10.1016/S0041-1345(97)00046-8</Handle></Occurrence>

40.	Hanzel, D. K., Trojanowski, J. Q., Johnston, R., and Loring, J. F. (1999) High throughput quantitative histological analysis of Alzheimer’s disease pathology using a confocal fluorescence microscanner. Nat. Biotechnol. 17, 53–57.

41.	Shenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., et al. (1999) Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177.

Comments (Loading...)

Post comment/View all comments